Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,585 | 32,565 | 12,676 | 9,832 | 9,497 |
| Marketable Securities | 8,977 | 5,481 | 7,575 | 15,933 | 21,219 |
| Receivables | 4 | 276 | 24,572 | 24,294 | 23,940 |
| TOTAL | $43,999 | $39,736 | $46,200 | $52,284 | $57,519 |
| Non-Current Assets | |||||
| PPE Net | 5,630 | 4,849 | 7,142 | 7,539 | 8,175 |
| Intangibles | 57,704 | 57,839 | 58,089 | 58,422 | 58,920 |
| Other Non-Current Assets | 616 | 666 | 649 | 637 | 864 |
| TOTAL | $63,950 | $63,354 | $65,880 | $66,598 | $67,959 |
| Total Assets | $107,949 | $103,090 | $112,080 | $118,882 | $125,478 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,813 | 7,214 | 5,948 | 5,321 | 5,226 |
| Other current liabilities | 194 | 3 | 33 | N/A | 45 |
| TOTAL | $7,769 | $7,751 | $7,519 | $6,969 | $6,494 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 46 | 297 | 408 | N/A |
| Other Non-Current Liabilities | 2,938 | 2,001 | 3,499 | 3,803 | 4,219 |
| TOTAL | $5,053 | $5,155 | $6,868 | $7,155 | $7,737 |
| Total Liabilities | $12,822 | $12,906 | $14,387 | $14,124 | $14,231 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 161,638 | 149,992 | 149,981 | 149,821 | 149,808 |
| Common Shares | 393,944 | 388,190 | 388,271 | 387,686 | 387,062 |
| Retained earnings | -294,078 | -296,103 | -288,343 | -281,821 | -273,422 |
| Other shareholders' equity | -4,739 | -1,903 | -2,235 | -1,107 | -2,393 |
| TOTAL | $95,127 | $90,184 | $97,693 | $104,758 | $111,247 |
| Total Liabilities And Equity | $107,949 | $103,090 | $112,080 | $118,882 | $125,478 |